(RTTNews) - Wednesday, pharmaceutical companies Forest Laboratories, Inc. (FRX: News ) and Cypress Bioscience, Inc. (CYPB: News ) said that the U.S. Food and Drug Administration approved Savella, a selective serotonin and norepinephrine dual reuptake ...
Original post: Forest and Cypress announce FDA approval of Savella for the management ... - RTT News
- Recent posts
- Alzheimer?s patients, families, caregivers gain local resources - Longview News-Journal
- Forest and Cypress announce FDA approval of Savella for the management ... - RTT News
- Pain Management Professional Search Page | Infopirate.org
- Vartabedian to exhibit photos of Armenia - Eagle-Tribune
- Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete ... - News-Medical.Net
- Rell to phase out deputy commissioners - Norwalk Hour
- Textbook of Regional Anesthesia and Acute Pain Management by Admir ...
- risky? - HealthBoards Message Boards
- Pain Management Class: How To Change A Habit | How To Cope With ...
- New HHS "conscience" rule jeopardizes end-of-life pain care - Huffingtonpost.com
- Adolor Corporation Announces Management Appointments - Earthtimes
- Doctor on Probation for Prescribing Excessive Pain Medication - WOWK
- Depomed’s License Agreement With Solvay Pharmaceuticals Clears HSR ... - Genetic Engineering News
- Pain Management Class 2009 | How To Cope With Pain Blog
- Pain Management Might Be The Solution For Your Chronic Back Pain...
- Endo Shifts Gears With Indevus - Forbes
- Stolen marijuana reported - Evansville Courier-Press
- Biovail voluntarily recalls certain lots of Ultram ER 100mg tablets ... - RTT News
- Naprapathy: A Hands-On Approach to Pain Management - Health News ...
- Why acupuncture? - Fort Lauderdale Sun-Sentinel